#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Treatment of psoriatic arthritis with biological agents


Authors: J. Štolfa
Authors‘ workplace: Revmatologický ústav, Praha
Published in: Čes. Revmatol., , 2004, No. 4, p. 175-183.
Category:

Overview

Psoriatic arthritis is a potentially serious disorder leading to a significant disability in 20–30 % ofpatients. Pharmacological treatment is limited to non-steroidal anti-inflammatory drugs, sulfasalazine,methotrexate and cyclosporine A. In contrast to rheumatoid arthritis, there has not been anybiological agent registered in the Czech Republic yet. The registration is expected in 2005. Indicationcriteria and methods of monitoring of biological treatment before its assumed registration in2005 are summarized in the present paper.

Key words:
psoriatic arthritis, biologic treatment, standard methods

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Dermatology & STDs Paediatric rheumatology Rheumatology
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#